Dr Bryan Clark Mccann, MD | |
424 North Washington St, Marksville, LA 71351 | |
(318) 253-8136 | |
(318) 253-5198 |
Full Name | Dr Bryan Clark Mccann |
---|---|
Gender | Male |
Speciality | General Practice |
Experience | 54 Years |
Location | 424 North Washington St, Marksville, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548218969 | NPI | - | NPPES |
10129 | Other | BLUE CROSS | |
1111520 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 11407 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bryan Clark Mccann, MD 424 North Washington St, Marksville, LA 71351 Ph: (318) 253-8136 | Dr Bryan Clark Mccann, MD 424 North Washington St, Marksville, LA 71351 Ph: (318) 253-8136 |
News Archive
The Adolescent and Adult Congenital Heart Disease (ACHD) Program at Cincinnati Children's Hospital Medical Center is one of a handful of programs in the nation to be awarded accreditation by the Adult Congenital Heart Association (ACHA).
The walls have been painted, the new floor tiles have been set and new science equipment has been installed in time for the dedication of the University of Florida Southwest Florida Research and Education Center's 7,000-square-foot expansion. The dedication ceremony is set for Tuesday, Jan. 5, at 10 a.m.
Palliative care is not just about pain relief, albeit an important component, but embraces a wide range of patient care, with the aim of improving the quality of a patient's life and upholding his or her sense of dignity. Palliative care - not to be confused with 'care at any cost'- implies the involvement of patients' families, as active caregivers as well as people to take care of: their quality of life is also a primary objective.
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.
› Verified 1 days ago
Dr. Richard Roy Michel, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 110 La Rue Medecine St, Marksville, LA 71351 Phone: 318-253-6564 Fax: 318-253-8256 |